| Name | AR-C118925XX |
|---|---|
| Synonyms |
AR-C118925XX
2-Furancarboxamide, 5-[[5-(2,8-dimethyl-5H-dibenzo[a,d]cyclohepten-5-yl)-3,4-dihydro-2-oxo-4-thioxo-1(2H)-pyrimidinyl]methyl]-N-1H-tetrazol-5-yl- 5-{[5-(2,8-Dimethyl-5H-dibenzo[a,d][7]annulen-5-yl)-2-oxo-4-thioxo-3,4-dihydro-1(2H)-pyrimidinyl]methyl}-N-(1H-tetrazol-5-yl)-2-furamide |
| Description | AR-C118925XX is a selective P2Y2 receptor antagonist. AR-C118925XX inhibits ATP-induced IL-6 production and phosphorylation of p38. AR-C118925XX also inhibits Bleomycin (HY-108345)-induced dermal fibrosis in mice. AR-C118925XX also inhibits ATP-induced tumor growth[1][2]. |
|---|---|
| Related Catalog | |
| Target |
P2Y2 Receptor |
| In Vivo | AR-C118925XX (i.p.) 抑制 Bleomycin 对小鼠真皮厚度的增加[1]。 |
| References |
| Density | 1.5±0.1 g/cm3 |
|---|---|
| Molecular Formula | C28H23N7O3S |
| Molecular Weight | 537.592 |
| Exact Mass | 537.158325 |
| LogP | 4.78 |
| Index of Refraction | 1.756 |